Outcomes after transcatheter mitral valve implantation in valve‐in‐valve, valve‐in‐ring, and valve‐in‐mitral annular calcification
Catheterization and Cardiovascular Interventions · 2024
DOI: 10.1002/ccd.31166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2024. Verfasst von Hector A Alvarez-Covarrubias und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany. Hauptthemen laut MEDLINE: Heart Valve Prosthesis, Mitral Valve, Heart Valve Prosthesis Implantation, Calcinosis. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aims
We aimed to evaluate transcatheter mitral valve implantation (TMVI) using predominantly balloon‐expandable transcatheter heart valves (THV) in patients with a landing zone for a percutaneously delivered prosthesis.
Background
Patients with a degenerated mitral valve bioprosthesis, annuloplasty ring, and mitral annulus calcification (MAC) considered at high surgical risk currently represent a treatment challenge. TMVI is an alternative treatment option.
Methods
Retrospective analysis of patients with symptomatic degenerated mitral valve bioprosthesis, or annuloplasty ring, and MAC treated with TMVI between November 2011 and April 2021. Endpoints were defined according to Mitral Valve Academic Research Consortium (MVARC) criteria and included device and procedure success at 30 days as well as mortality at 30 days and 1 year after the procedure.
Results
A total of 77 patients underwent TMVI (valve in valve [ViV = 56], valve in ring [ViR = 11], and valve in MAC [ViMAC = 10]). There was a trend toward higher technical success (all = 93.5%, ViV = 96.4%, ViR = 90.9%, ViMAC = 80%, p = 0.06) and lower 30‐day (all = 11.7%, ViV = 10.7%, ViR = 9.1%, ViMAC = 20%, p = 0.49) and 1‐year mortality (all = 26%, ViV = 23.2%, ViR = 27.3%, ViMAC= 40%, p = 0.36) after ViV and ViR compared to ViMAC.
Conclusion
TMVI represents a reasonable treatment option in selected patients with MAC or who are poor candidates for redo mitral valve surgery. Technical success and survival up to 1 year were not significantly dependent on the subgroup in which TMVI was performed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
- Departamento de Cardiología, Hospital de Cardiología, Centro Médico Nacional Siglo XXI, IMSS, Mexico City, Mexico.
- DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
- Department of Cardiac Surgery, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
- Institut für Anästhesiologie, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
- First Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
ORCID-Profile: Hector A Alvarez-Covarrubias, Erion Xhepa, N Patrick Mayr, Salvatore Cassese, Adnan Kastrati, Magdalena Erlebach
Zitieren
APA
Alvarez-Covarrubias, H. A., Joner, M., Lutz, M., Xhepa, E., Mayr, N. P., Lachmann, M., Cassese, S., Rheude, T., Pellegrini, C., Kufner, S., Schunkert, H., Kastrati, A., Erlebach, M., Lange, R., & Ruge, H. (2024). Outcomes after transcatheter mitral valve implantation in valve‐in‐valve, valve‐in‐ring, and valve‐in‐mitral annular calcification. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31166
Vancouver
Alvarez-Covarrubias HA, Joner M, Lutz M, Xhepa E, Mayr NP, Lachmann M, et al. Outcomes after transcatheter mitral valve implantation in valve‐in‐valve, valve‐in‐ring, and valve‐in‐mitral annular calcification. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.31166
BibTeX
@article{AlvarezCovarrubias2024,
author = {Alvarez-Covarrubias, Hector A and Joner, Michael and Lutz, Marius and Xhepa, Erion and Mayr, N Patrick and Lachmann, Mark and Cassese, Salvatore and Rheude, Tobias and Pellegrini, Costanza and Kufner, Sebastian and Schunkert, Heribert and Kastrati, Adnan and Erlebach, Magdalena and Lange, Rüdiger and Ruge, Hendrik},
title = {Outcomes after transcatheter mitral valve implantation in valve‐in‐valve, valve‐in‐ring, and valve‐in‐mitral annular calcification},
journal = {Catheterization and Cardiovascular Interventions},
year = {2024},
doi = {10.1002/ccd.31166}
}
EUVIMED